Ticos Laboratories Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 21-06-2024
- Paid Up Capital ₹ 1.00 M
as on 21-06-2024
- Company Age 14 Year, 8 Months
- Last Filing with ROC 31 Mar 2022
- Revenue 208.33%
(FY 2021)
- Profit 46.59%
(FY 2021)
- Ebitda 293.88%
(FY 2021)
- Net Worth 40.59%
(FY 2021)
- Total Assets 152.31%
(FY 2021)
About Ticos Laboratories
The Corporate was formerly known as Incarta Pharma Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M, as per Ministry of Corporate Affairs (MCA) records.
Payal Patel and Jaynesh Patel serve as directors at the Company.
- CIN/LLPIN
U24239GJ2010PTC060303
- Company No.
060303
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
19 Apr 2010
- Date of AGM
30 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Ticos Laboratories?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jaynesh Patel  | Director | 19-Apr-2010 | Current |
| Payal Patel | Director | 16-Mar-2019 | Current |
Financial Performance of Ticos Laboratories.
Ticos Laboratories Private Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 208.33% increase. The company also saw a substantial improvement in profitability, with a 46.59% increase in profit. The company's net worth Soared by an impressive increase of 40.59%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ticos Laboratories?
In 2021, Ticos Laboratories had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Ticos Omega Pharmaceuticals Private LimitedActive 4 years 10 months
Payal Patel and Jaynesh Patel are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Ticos Laboratories?
Unlock and access historical data on people associated with Ticos Laboratories, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ticos Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ticos Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
